Original paperDetection of residual tumours in postchemotherapy testicular cancer by FDG-PET
References (28)
- et al.
Predictors of residual mass requiring resection after chemotherapy of stage III testicular cancer. A prospective study
Urology
(1992) Decision making in abdominal surgery following chemotherapy for testicular cancer
Eur J Cancer
(1995)- et al.
Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and flourine-18-fiuorodeoxyglucose
Blood
(1995) - et al.
Cancer of testis
Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility and exercise
Br Med J
(1994)- et al.
Salvage therapy for germ cell tumors
- et al.
Current perspectives on the role of the adjuvant surgery in combined mortality treatment for patient with germ cell tumours
- et al.
CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous tumors: can residual malignancy or teratoma be excluded?
Radiology
(1991) - et al.
The applications of PET in clinical oncology
J Nucl Med
(1991)
Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of (18F)-2-deoxy-fluoro-d-glucose
J Nucl Med
(1978)
Positron emission tomography using (18F)fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool
Invest Radiol
(1987)
Noninvasive grading of musculoskeletal tumors using PET
J Nucl Med
(1991)
Head and neck cancer: detection of recurrence with positron emission tomography and 2-(18F)fluoro-2-deoxy-d-glucose
Radiology
(1995)
Cited by (0)
Copyright © 1997 Published by Elsevier Ltd.